 Home > Active Ingredient News > Immunology News > Rheumatology: Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis (EGPA)

Rheumatology: Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis (EGPA)

 Last Update: 2022-08-16
 Source: Internet
 Author: User

Tags

anti neutrophil cytoplasmic antibody

ultrasound fat cavitation

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Objectives: Patients affected by eosinophilic granulomatosis with polyangiitis (EGPA) are at increased risk of atherothrombotic events compared with the general populatio.

Eosinophilic granulomatosis with polyangiitis (EGPA) eosinophilic granulomatosis with polyangiitis ( EGPA ) vascular atherosclerosis atherothrombotic (ANCA) associated vasculitis (AAV) subclinical markers

Methods: Forty EGPA patients and 80 controls (matched for age, sex, and traditional cardiovascular risk factors) underwent ultrasound assessment of common carotid artery (CCA) intima-media thickness (IMT.

Correlation between CCA-IMT and clinical and laboratory features in common carotid artery (CCA) intima-media thickness (IMT) ultrasound assessment

Results: The median CCA-IMT of EGPA patients was significantly higher than that of controls ( p = 00

p significantly higher p

No significant correlations were found between CCA-IMT, ANCA status, other clinical features, and treatment regimens

No significant correlations were found between CCA-IMT, ANCA status, other clinical features, and treatment regimens were comparable

Conclusions: Ultrasound markers of subclinical atherosclerosis were increased in patients with EGPA compared with controls , independent of traditional cardiovascular risk facto.

Ultrasound markers of subclinical atherosclerosis increased in EGPA patients, independent of traditional cardiovascular risk factors Ultrasound markers of subclinical atherosclerosis increased in EGPA patients, independent of traditional cardiovascular risk factors

Source:

Bello F, Bettiol A, Silvestri E, et .

Bello F, Bettiol A, Silvestri E, et .
Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA) [published online ahead of print, 2022 Jul 2
Rheumatology (Oxfor.
2022;keac42 doi:11093/rheumatology /keac427 leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.